{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T18:51:44Z","timestamp":1784746304947,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.intimp.2024.111737","type":"journal-article","created":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T00:45:45Z","timestamp":1708735545000},"page":"111737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Morita-Baylis-Hillman adduct 2-(3-hydroxy-1-methyl-2-oxoindolin-3-il) acrylonitrile (CISACN) ameliorates the pulmonary allergic inflammation in CARAS model by increasing IFN-\u03b3\/IL-4 ratio towards the Th1 immune response"],"prefix":"10.1016","volume":"130","author":[{"given":"Larissa","family":"Adilis Maria Paiva Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00e9rcia","family":"Karla Diega Paiva Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Fragoso Pereira Cavalcanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Allysson de Assis Ferreira Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Mangueira de Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Francisco Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio","family":"Gabriel Lima J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"Regina Piuvezam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.111737_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105718","article-title":"Combined allergic rhinitis and asthma syndrome (CARAS)","volume":"74","author":"Paiva Ferreira","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0010","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jaip.2022.07.020","article-title":"The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis","volume":"10","author":"Bousquet","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.intimp.2024.111737_b0015","first-page":"1761","article-title":"Correlation between upper and lower airway inflammations in patients with combined allergic rhinitis and asthma syndrome: A comparison of patients initially presenting with allergic rhinitis and those initially presenting with asthma","volume":"15","author":"Xia","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.111737_b0020","article-title":"The Burden of Asthma and Allergic Rhinitis","author":"Patel","year":"2023","journal-title":"Otolaryngol. Clin. North Am."},{"key":"10.1016\/j.intimp.2024.111737_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106938","article-title":"4-Carvomenthenol ameliorates the murine combined allergic rhinitis and asthma syndrome by inhibiting IL-13 and mucus production via p38MAPK\/NF-\u03baB signaling pathway axis","volume":"88","author":"Bezerra Barros","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152721","article-title":"Limosilactobacillus fermentum modulates the gut-airway axis by improving the immune response through FOXP3 activation on combined allergic rhinitis and asthma syndrome (CARAS)","author":"Cavalcanti","year":"2023","journal-title":"Immunobiology 228"},{"key":"10.1016\/j.intimp.2024.111737_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2021.104540","article-title":"Immunomodulatory properties of Musa paradisiaca L. inflorescence in Combined Allergic Rhinitis and Asthma Syndrome (CARAS) model towards NF\u03baB pathway inhibition","volume":"83","author":"Gadelha","year":"2021","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.intimp.2024.111737_b0040","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.intimp.2015.06.028","article-title":"Intranasal administration of CpG oligodeoxynucleotides reduces lower airway in fl ammation in a murine model of combined allergic rhinitis and asthma syndrome","volume":"28","author":"Li","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.intimp.2019.05.021","article-title":"TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model","volume":"73","author":"Tang","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0050","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1365-2222.2009.03417.x","article-title":"United airways: Circulating Th2 effector cells in an allergic rhinitis model are responsible for promoting lower airways inflammation","volume":"40","author":"Kleinjan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.intimp.2024.111737_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8163803","article-title":"IgE-Related Chronic Diseases and Anti-IgE-Based Treatments","volume":"2016","author":"Navin\u00e9s-Ferrer","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.intimp.2024.111737_b0060","article-title":"Treatment of allergic rhinitis with CpG oligodeoxynucleotides alleviates the lower airway outcomes of combined allergic rhinitis and asthma syndrome via a mechanism that possibly involves in TSLP airway outcomes of combined allergic rhinitis and asthma sy","volume":"2148","author":"Li","year":"2016","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.intimp.2024.111737_b0065","doi-asserted-by":"crossref","unstructured":"H. Tao Li, Z. Gui Chen, Y. Sen Lin, H. Liu, J. Ye, X. Ling Zou, Y. Hong Wang, H. Ling Yang, T. Tuo Zhang, CpG-ODNs and Budesonide Act Synergistically to Improve Allergic Responses in Combined Allergic Rhinitis and Asthma Syndrome Induced by Chronic Exposure to Ovalbumin by Modulating the TSLP-DC-OX40L Axis, Inflammation (2018) 1\u201317. https:\/\/doi.org\/10.1007\/s10753-018-0779-6.","DOI":"10.1007\/s10753-018-0779-6"},{"key":"10.1016\/j.intimp.2024.111737_b0070","doi-asserted-by":"crossref","first-page":"15377","DOI":"10.3390\/ijms232315377","article-title":"Artemisia gmelinii extract alleviates allergic airway inflammation via balancing TH1\/TH2 homeostasis and inhibiting mast cell degranulation","volume":"23","author":"Van Nguyen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111737_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1218030","article-title":"Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation","volume":"14","author":"Feng","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0080","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.4049\/jimmunol.178.4.2491","article-title":"Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3","volume":"178","author":"Maneechotesuwan","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.111737_b0085","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3390\/biom5031266","article-title":"NF-kappaB signaling in chronic inflammatory airway disease","volume":"5","author":"Schuliga","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/j.intimp.2024.111737_b0090","first-page":"1149","article-title":"Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization","volume":"23","author":"Bengtson","year":"2017","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.intimp.2024.111737_b0095","first-page":"1691","article-title":"Biological Activities of Morita-Baylis-Hillman Adducts (MBHA), Mini-Reviews","volume":"23","author":"Paiva Ferreira","year":"2023","journal-title":"Med. Chem."},{"key":"10.1016\/j.intimp.2024.111737_b0100","series-title":"Modulates Inflammatory Process in Vitro and in Vivo, Inflammation","first-page":"1","article-title":"Morita-Baylis-Hillman Adduct 2-(3-Hydroxy-2-oxoindolin-3-yl)acrylonitrile (ISACN)","author":"de Fran\u00e7a","year":"2020"},{"key":"10.1016\/j.intimp.2024.111737_b0105","first-page":"602","article-title":"Synthesis, Cytotoxic Activity on Leukemia Cell Lines and Quantitative Structure-Activity Relationships (QSAR) Studies of Morita-Baylis-Hillman Adducts","volume":"12","author":"Lima-Junior","year":"2016","journal-title":"Med. Chem. (los Angeles)"},{"key":"10.1016\/j.intimp.2024.111737_b0110","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/j.bmc.2012.04.061","article-title":"Morita-Baylis-Hillman adducts: Biological activities and potentialities to the discovery of new cheaper drugs","volume":"20","author":"Lima-Junior","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.intimp.2024.111737_b0115","article-title":"Atividade antiplasmodial in vitro de um derivado da N-metil-isatina (CH3ISACN), e sua toxicidade in silico e in vivo","author":"Melo","year":"2020","journal-title":"Universidade Federal Da Para\u00edba"},{"key":"10.1016\/j.intimp.2024.111737_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107590","article-title":"MHTP, a synthetic alkaloid, attenuates combined allergic rhinitis and asthma syndrome through downregulation of the p38\/ERK1\/2 MAPK signaling pathway in mice","volume":"96","author":"Paiva Ferreira","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107590","article-title":"MHTP, a synthetic alkaloid, attenuates combined allergic rhinitis and asthma syndrome through downregulation of the p38\/ERK1\/2 MAPK signaling pathway in mice","volume":"96","author":"Paiva Ferreira","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0130","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jim.2004.03.004","article-title":"A rapid flow cytometric method for determining the cellular composition of bronchoalveolar lavage fluid cells in mouse models of asthma","volume":"288","author":"Van Rijt","year":"2004","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.intimp.2024.111737_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106616","article-title":"Warifteine and methylwarifteine inhibited the type 2 immune response on combined allergic rhinitis and asthma syndrome (CARAS) experimental model through NF-\u043aB pathway","volume":"85","author":"Cavalcanti","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.intimp.2010.03.007","article-title":"Effect of 5-aminosalicylate on allergic rhinitis model in mice","volume":"10","author":"Kuyama","year":"2010","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114959","article-title":"Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg\/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model","author":"Jiang","year":"2023","journal-title":"Biomedicine & Pharmacotherapy 164"},{"key":"10.1016\/j.intimp.2024.111737_b0150","doi-asserted-by":"crossref","first-page":"12514","DOI":"10.3390\/ijms241512514","article-title":"Fallopia japonica Root Extract Ameliorates Ovalbumin-Induced Airway Inflammation in a CARAS Mouse Model by Modulating the IL-33\/TSLP\/NF-\u03baB Signaling Pathway","volume":"24","author":"Jin","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.111737_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110254","article-title":"PM2.5 exposure regulates Th1\/Th2\/Th17 cytokine production through NF-\u03baB signaling in combined allergic rhinitis and asthma syndrome","author":"Piao","year":"2023","journal-title":"Int Immunopharmacol 119"},{"key":"10.1016\/j.intimp.2024.111737_b0160","doi-asserted-by":"crossref","first-page":"e13444","DOI":"10.7717\/peerj.13444","article-title":"IL-4\/IL-13 axis as therapeutic targets in allergic rhinitis and asthma","volume":"10","author":"Nur Husna","year":"2022","journal-title":"PeerJ"},{"key":"10.1016\/j.intimp.2024.111737_b0165","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00210-023-02404-w","article-title":"Network pharmacology and molecular docking to explore the potential mechanism of urolithin A in combined allergic rhinitis and asthma syndrome","volume":"396","author":"Cong","year":"2023","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108509","article-title":"CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model","volume":"104","author":"Dai","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.111737_b0175","article-title":"The biology of eosinophils and their role in asthma","volume":"4","author":"McBrien","year":"2017","journal-title":"Front. Med. (lausanne)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:19:23Z","timestamp":1761589163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"alternative-id":["S1567576924002558"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111737","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morita-Baylis-Hillman adduct 2-(3-hydroxy-1-methyl-2-oxoindolin-3-il) acrylonitrile (CISACN) ameliorates the pulmonary allergic inflammation in CARAS model by increasing IFN-\u03b3\/IL-4 ratio towards the Th1 immune response","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.111737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111737"}}